France vs Sweden: Reported rate of new cervical cancer cases
France
6.89 per 100,000 women
in 2017
Sweden
7.48 per 100,000 women
in 2022
France rank
27th
Sweden rank
25th
Reported rate of new cervical cancer cases over time
- France
- Sweden
How they compare
Sweden currently reports 7.48 per 100,000 women against 6.89 per 100,000 women in France, a difference of 0.59 per 100,000 women.
That makes Sweden's figure about 1.1 times France's.
The two have swapped places 5 times across 20 shared years of data; in 1998 it was France ahead.
France ranks 27th and Sweden ranks 25th of 46 countries.
Across the 3 decades both report, France averaged higher in 1 and Sweden in 2.
Head to head by decade
| Decade | France | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.72 per 100,000 women | 6.92 per 100,000 women | 0.8036 per 100,000 women | France |
| 2000s | 6.74 per 100,000 women | 7 per 100,000 women | 0.2567 per 100,000 women | Sweden |
| 2010s | 6.28 per 100,000 women | 8.16 per 100,000 women | 1.88 per 100,000 women | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, France or Sweden?
- Sweden, at 7.48 per 100,000 women against 6.89 per 100,000 women in France as of 2022.
- What is the difference in reported rate of new cervical cancer cases between France and Sweden?
- 0.59 per 100,000 women, with Sweden ahead.
- How many years of comparable data are there for France and Sweden?
- 20 years are reported by both, from 1998 to 2017.
- How do France and Sweden rank globally for reported rate of new cervical cancer cases?
- France ranks 27th and Sweden ranks 25th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.